Hybrid Designs in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Hybrid Designs in Clinical Trials in Brazil

Hybrid Designs in Clinical Trials in Brazil – Full Service CRO

Clinical trials are pivotal in medical research, serving as essential tools for evaluating new treatments and therapies. While randomized controlled trials (RCTs) have long been the gold standard, hybrid designs have emerged as a revolutionary approach to address various challenges faced during conventional trials.

In Brazil, a nation with a vibrant research ecosystem and diverse patient population, hybrid designs are gaining prominence. This blog explores the significance of hybrid designs in advancing medical research within the Brazilian context.

Understanding Hybrid Designs

Hybrid designs in clinical trials combine elements of traditional RCTs with other research methodologies, such as observational studies or pragmatic trials. The motivation behind these designs lies in overcoming the limitations of RCTs, including high costs, lengthy timelines, and ethical concerns. By amalgamating different approaches, hybrid designs offer increased flexibility, cost-effectiveness, and more efficient ways of conducting clinical trials.

Advantages of Hybrid Designs

  1. Enhanced Flexibility: Hybrid designs allow researchers to adapt the trial protocol as new data emerges or objectives change. This adaptability ensures that the study remains relevant and accurate throughout its duration.
  2. Improved Patient Recruitment: In Brazil, recruiting a diverse and representative patient population for clinical trials can be challenging. Hybrid designs can leverage real-world data or existing patient registries, simplifying the recruitment process and broadening the scope of the study.
  3. Cost-Effectiveness: By incorporating real-world data or repurposing existing trials, hybrid designs can significantly reduce research costs, making them a more financially viable option for medical research in Brazil.
  4. Ethical Considerations: In situations where randomization to a control group without treatment raises ethical concerns, hybrid designs can utilize real-world evidence or historical data to mitigate the need for a placebo or control group.

Hybrid Designs in Clinical Trials in Brazil

Hybrid Designs in Clinical Trials in Brazil

Hybrid Designs in Clinical Trials in Brazil

Applications of Hybrid Designs in Brazil

  1. Rare Diseases Research: For rare diseases, finding a sufficient number of participants for conventional RCTs can be daunting. Hybrid designs that integrate real-world data or leverage patient registries can provide invaluable insights into these challenging medical conditions.
  2. Adaptive Trials: Adaptive designs enable researchers to modify the trial’s parameters based on accumulating data. In Brazil, where patient demographics and disease patterns may vary significantly, adaptive designs can personalize treatments and optimize outcomes.
  3. Comparative Effectiveness Research: Hybrid designs are well-suited for comparative effectiveness studies, evaluating different treatments in real-world scenarios and catering to Brazil’s diverse patient population.
  4. Post-Marketing Surveillance: Hybrid designs can be employed for post-marketing surveillance, continuously monitoring the safety and effectiveness of newly approved drugs or treatments.

Challenges and Considerations

While hybrid designs offer numerous advantages, they also present specific challenges that Brazilian researchers should be mindful of:

  1. Data Quality and Integration: Integrating data from various sources may introduce challenges related to data quality and compatibility. Establishing robust data management systems is crucial to overcome these hurdles.
  2. Regulatory Compliance: As hybrid designs may differ from traditional RCTs, researchers must ensure compliance with local and international regulatory guidelines.
  3. Statistical Expertise: Analyzing hybrid trials may necessitate specialized statistical methods, requiring researchers to possess the necessary expertise to ensure the validity and reliability of their findings.


Hybrid designs in clinical trials hold immense promise for advancing medical research in Brazil. By combining the strengths of different research methodologies, these designs offer enhanced flexibility, cost-effectiveness, and improved patient recruitment.

Their applications span from rare diseases research to comparative effectiveness studies, contributing significantly to Brazil’s healthcare landscape. To fully harness the potential of hybrid designs, Brazilian researchers must address challenges related to data integration, regulatory compliance, and statistical analysis.

By embracing innovation and collaboration, Brazil’s research community can lead the way in pioneering medical discoveries and delivering accessible healthcare solutions to its diverse population.

Hybrid Designs in Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Hybrid Designs in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Hybrid Designs in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Hybrid Designs in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Hybrid Designs in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Hybrid Designs in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Hybrid Designs in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Hybrid Designs in Clinical Trials in Brazil

The Cohortias Team

Hybrid Designs in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Hybrid Designs in Clinical Trials in Brazil

Network & Partnerships